Modulating the Physical Form of Mannitol Crystallizing in Frozen Solutions: The Role of Cosolute and Processing
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c01481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Chaowang Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Mannitol. Die Arbeit nennt 26 Literaturangaben. Gefördert von: NSF through the MRSEC program, National Institute for Pharmaceutical Technology and Education, Rigaku Americas Corporation.
Abstract (Originalsprache)
Mannitol is widely employed as a bulking agent in lyophilized formulations. Our goal was to evaluate the role of noncrystallizing cosolutes in inhibiting mannitol crystallization and preventing the formation of mannitol hemihydrate (MHH) in frozen solutions. The individual influence of two common stabilizers (sucrose and trehalose) and three model proteins (lysozyme, bovine serum albumin, and immunoglobulin G) on the crystallization behavior of mannitol was investigated by differential scanning calorimetry (DSC) and X-ray diffractometry (XRD). Sugars exerted a more pronounced crystallization inhibitory effect than proteins. In the presence of sugars, mannitol predominantly crystallized as MHH while the proteins facilitated the crystallization of δ-mannitol. Annealing the frozen solutions at -25 °C favored MHH crystallization. A higher annealing temperature of -10 °C accelerated mannitol crystallization and promoted the formation of the anhydrous δ-polymorph. The crystallization inhibitory effect of proteins was surmounted with annealing, while at a high sugar concentration, a substantial fraction of mannitol was retained amorphous even after annealing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- Rigaku Americas, The Woodlands, Texas 77381-5209, United States.
ORCID-Profile: Jinghan Li, Bhushan Munjal, Raj Suryanarayanan
Förderung
- NSF through the MRSEC program
- National Institute for Pharmaceutical Technology and Education
- Rigaku Americas Corporation
- William and Mildred Peters Endowment fund
Zitieren
APA
Zeng, C., Li, J., Shi, J., Bates, S., Munjal, B., & Suryanarayanan, R. (2025). Modulating the Physical Form of Mannitol Crystallizing in Frozen Solutions: The Role of Cosolute and Processing. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01481
Vancouver
Zeng C, Li J, Shi J, Bates S, Munjal B, Suryanarayanan R. Modulating the Physical Form of Mannitol Crystallizing in Frozen Solutions: The Role of Cosolute and Processing. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01481
BibTeX
@article{Zeng2025,
author = {Zeng, Chaowang and Li, Jinghan and Shi, Jiawanjun and Bates, Simon and Munjal, Bhushan and Suryanarayanan, Raj},
title = {Modulating the Physical Form of Mannitol Crystallizing in Frozen Solutions: The Role of Cosolute and Processing},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c01481}
}
EUVIMED